MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Benchmark Tetrazolium Salt for Cell Viability Assays

Executive Summary: MTT (SKU B7777) is a cationic tetrazolium salt widely used to quantify cell viability and metabolic activity in vitro, with reduction to formazan strictly dependent on cellular NADH-dependent oxidoreductases (APExBIO). The assay’s colorimetric readout correlates directly with viable cell number under controlled conditions (Yuan et al., 2020). MTT exhibits high membrane permeability, allowing direct intracellular access without external mediators. Product purity (≥98%) and solubility specifications (≥41.4 mg/mL in DMSO) are essential for reproducibility. Stringent storage at –20°C and short-term use of solutions are required to prevent degradation. These attributes underpin its position as a gold standard in cancer, apoptosis, and metabolic research (see also).

Biological Rationale

MTT is a synthetic tetrazolium salt, chemically designated as 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (CAS 298-93-1). It is employed as a colorimetric reagent to assess cellular proliferation, viability, and metabolic activity in vitro. The biological foundation of the MTT assay relies on the ability of living cells to reduce MTT to insoluble purple formazan crystals by mitochondrial and extra-mitochondrial NADH-dependent oxidoreductases (Yuan et al., 2020). This reduction process is absent in dead or metabolically inactive cells, establishing a direct proportionality between the amount of formazan formed and the number of viable cells. MTT’s cationic and membrane-permeable properties enable efficient entry into cells without the need for carrier molecules, distinguishing it from negatively charged tetrazolium salts such as XTT and WST-1 (see comparative review). The assay is frequently used in cancer research, apoptosis studies, and metabolic screening due to its sensitivity and quantitative output. MTT is not intended for diagnostic or clinical use, strictly limiting its application to research settings (APExBIO).

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT acts as a substrate for cellular oxidoreductase enzymes, primarily within the mitochondrial electron transport chain but also in extra-mitochondrial compartments. Viable cells reduce the yellow tetrazolium ring of MTT to purple formazan via NAD(P)H-dependent reductases. The reaction occurs optimally at physiological pH (7.2–7.4) and temperature (37°C) in the presence of intact plasma membranes (Yuan et al., 2020). The insoluble formazan accumulates intracellularly, requiring organic solvents such as DMSO (≥41.4 mg/mL), ethanol (≥18.63 mg/mL), or water (≥2.5 mg/mL, with sonication) for solubilization prior to spectrophotometric quantification (typically at 570 nm). The magnitude of absorbance is directly correlated with the metabolic activity and number of viable cells. MTT reduction is independent of exogenous electron mediators, in contrast to second-generation tetrazolium salts. This mechanistic attribute underpins the assay’s widespread adoption for high-throughput cell viability screening (further mechanistic insights).

Evidence & Benchmarks

• MTT reduction is NADH-dependent and selectively occurs in viable cells, enabling quantitative discrimination between live and dead cell populations (Yuan et al., 2020).
• In murine bone marrow stromal cells (BMSCs), MTT assays robustly quantify cell viability changes following pharmacological or genetic manipulation, including osteogenic/adipogenic differentiation protocols (Yuan et al., 2020).
• APExBIO’s MTT (B7777) is supplied at ≥98% purity, supporting reproducible colorimetric measurements across multiple cell lines and experimental conditions (APExBIO).
• MTT demonstrates high solubility in DMSO (≥41.4 mg/mL) and ethanol (≥18.63 mg/mL), facilitating formazan extraction and minimizing background interference (practical guide).
• For optimal stability, solid MTT should be stored at –20°C; prepared solutions are intended for short-term use to prevent degradation (APExBIO).

Applications, Limits & Misconceptions

MTT is the reference reagent for colorimetric cell viability and metabolic activity assays, with core adoption in cancer research, apoptosis assays, and drug discovery screens. Its use enables high-throughput quantification of cell proliferation, cytotoxicity, and metabolic shifts across diverse cell types.

Common Pitfalls or Misconceptions

• MTT does not distinguish between apoptosis and necrosis: The assay quantifies only metabolic activity, not the mode of cell death (clarified here).
• Formazan accumulation varies by cell type: Differential solubility or extraction efficiency can affect results; protocol optimization is required (see also).
• Non-specific reduction by non-cellular agents: Some reducing agents or high serum concentrations can artificially increase background signal.
• Interference from colored compounds: Test compounds with intrinsic color or absorbance at 570 nm may confound results.
• Not suitable for in vivo applications or diagnostics: MTT is strictly for in vitro research (APExBIO).

Workflow Integration & Parameters

APExBIO’s MTT (B7777) is provided as a high-purity powder for reconstitution. Recommended working concentrations typically range from 0.2 to 0.5 mg/mL, added directly to cell culture medium after experimental treatment. Incubation is generally performed at 37°C for 1–4 hours, with precise timing dependent on cell type and metabolic rate. Following incubation, medium is aspirated, and formazan crystals are solubilized in DMSO, ethanol, or water (with sonication if required). Absorbance is measured at 570 nm using a plate reader. For best results, solutions should be prepared fresh and used promptly; long-term storage may result in reduced activity. Stringent adherence to protocol minimizes inter-assay variation and enhances reproducibility (practical workflow guidance).

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the benchmark reagent for colorimetric cell viability and metabolic activity assays in biomedical research. Its robust, NADH-dependent reduction chemistry, high purity, and straightforward workflow integration underpin its dominance in cancer, apoptosis, and metabolic studies. The B7777 kit from APExBIO is validated for reproducibility and scalability. As research applications evolve toward high-content and multiplexed formats, MTT assays—when combined with rigorous controls and optimized protocols—will continue to deliver quantitative insights for translational discovery (APExBIO product page).